|
⚲
|
| Keyboard |
| venBio Global Strategic GP III Ltd | |
|---|---|
| Firm | venBio Partners LLC |
| Address | c/o venBio Partners LLC 1700 Owens Street, Suite 595 San Francisco, CA 94158 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| venBio Partners LLC | |||||
| venBio Global Strategic Fund III LP | 021-314554 | Director | 386.1 M of 386.1 M |
393.5 M | |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Artiva Biotherapeutics Inc ARTV
Common Stock
|
2024-07-22 | Conversion | 843,592 | ||
|
Artiva Biotherapeutics Inc ARTV
Common Stock
|
2024-07-22 | Other | 461,687 | ||
|
Artiva Biotherapeutics Inc ARTV
Common Stock
|
2024-07-22 | Buy | 416,666 | $12.00 | 4,999,992 |
|
Artiva Biotherapeutics Inc ARTV
Common Stock
|
2024-07-22 | Conversion | 214,692 | ||
|
Artiva Biotherapeutics Inc ARTV
Series A Convertible Preferred Stock · derivative
|
2024-07-22 | Conversion | 843,592 | ||
|
Artiva Biotherapeutics Inc ARTV
Series B Convertible Preferred Stock · derivative
|
2024-07-22 | Conversion | 214,692 | ||
|
RayzeBio Inc RYZB
Common Stock
|
2023-09-19 | Conversion | 3,786,957 | ||
|
RayzeBio Inc RYZB
Common Stock
|
2023-09-19 | Conversion | 1,123,862 | ||
|
RayzeBio Inc RYZB
Common Stock
|
2023-09-19 | Conversion | 247,343 | ||
|
RayzeBio Inc RYZB
Series A Convertible Preferred Stock · derivative
|
2023-09-19 | Conversion | 3,786,957 | ||
|
RayzeBio Inc RYZB
Series B Convertible Preferred Stock · derivative
|
2023-09-19 | Conversion | 1,123,862 | ||
|
RayzeBio Inc RYZB
Series C Convertible Preferred Stock · derivative
|
2023-09-19 | Conversion | 216,127 | ||
|
Ventyx Biosciences Inc VTYX
Stock Option (right to buy) · derivative
|
2022-06-09 | Grant | 13,301 | $0.00 | |
|
Ventyx Biosciences Inc VTYX
Stock Option (right to buy) · derivative
|
2022-06-09 | Grant | 13,301 | $0.00 | |
|
Elevation Oncology Inc ELEV
Common Stock
|
2022-05-25 | Sell | 702,737 | $4.12 | 2,895,276 |
|
Ventyx Biosciences Inc VTYX
Series B Preferred Stock · derivative
|
2021-10-25 | Conversion | 395,027 | $0.00 | |
|
Ventyx Biosciences Inc VTYX
Common Stock
|
2021-10-25 | Buy | 312,500 | $16.00 | 5,000,000 |
|
Ventyx Biosciences Inc VTYX
Common Stock
|
2021-10-25 | Conversion | 3,684,769 | ||
|
Ventyx Biosciences Inc VTYX
Series A Preferred Stock · derivative
|
2021-10-25 | Conversion | 3,289,742 | $0.00 | |
|
Elevation Oncology Inc ELEV
Common Stock
|
2021-06-29 | Conversion | 1,983,167 | ||
| showing 20 of 22 most recent transactions | |||||